Pay in 4 interest-free payments of $6.23 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Wegovy by Novo Nordisk is priced at $1,349 in the U.S., and Eli Lillys Zepbound is priced at $1,060 for a 28-day supply, making these drugs unaffordable for a large portion of the population
As a result of ever-increasing unsanctioned scraping by bots, we have instituted a challenge designed to keep them out, and make sure real users get the best experience possible
After all, there are over 100 originator drugs and almost as many biosimilars in the pipeline, many of which will never progress to commercialisation, but some of which will further push the boundaries on patient convenience, efficacy and indication spectrum
Elsewhere, its biggest rival, Novo Nordisk, which makes Wegovy and Ozempic, spent its advertising dollars on an in-game ad featuring DJ Kahled and John C
Metabolic adaptation compounds the problem
